Warning: Patients Advised to Stop Using Weight Loss Drugs like Ozempic Before Surgery, Says American Society of Anesthesiologists

by time news

Weight Loss Drugs like Ozempic Warned to Stop Before Surgery

Patients who take weight loss drugs, specifically the popular medication Ozempic, have been urged to discontinue using these drugs prior to surgery that requires sedation. The American Society of Anesthesiologists (ASA) issued a warning stating that these medications could increase the risk of complications during surgery.

Ozempic, along with other weight loss drugs, is known to reduce appetite and can also treat diabetes by targeting the pancreas’ GLP-1 receptors. However, the ASA expressed concern regarding the lack of scientific data on how GLP-1 receptor agonists interact with anesthesia during surgery.

According to ASA President Michael Champeau, there have been reports of delays in stomach emptying associated with an increased risk of regurgitation and food aspiration into the airways and lungs during anesthesia and sedation. These complications can have serious consequences, prompting the ASA to provide guidance on when GLP-1 agonists should be discontinued before elective procedures.

Although GLP-1 receptor drugs are relatively new to the market, their interaction with the human body under anesthesia remains limited. The ASA is therefore recommending that patients scheduled for surgery skip their doses of weight loss drugs to minimize potential complications.

Ozempic, often dubbed a “miracle” weight loss drug, has faced regulatory concerns due to its rapid rise in popularity. Originally developed for diabetes treatment, it was found to have an additional benefit for weight loss, leading to its widespread use among celebrities. European Union regulators are currently investigating claims that the drug may increase suicidal ideation in patients, while other potential side effects are still being studied.

As the safety and effectiveness of weight loss drugs continue to be assessed, patients are advised to consult with their healthcare providers and follow the recommendations of the ASA regarding the discontinuation of these medications before undergoing surgery.

Copyright 2023 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

You may also like

Leave a Comment